相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib
Won Ick Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
I-Cheng Lee et al.
CANCERS (2022)
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet et al.
HEPATOLOGY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
Shousheng Liu et al.
FRONTIERS IN ONCOLOGY (2021)
First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study
Shigeo Shimose et al.
CANCER MEDICINE (2021)
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
Hao-Tian Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials
Lisha Mou et al.
FRONTIERS IN ONCOLOGY (2021)
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy
Wuzheng Xia et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
Masatoshi Kudo et al.
LIVER CANCER (2021)
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
Hung-Wei Wang et al.
CANCERS (2021)
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
Masatoshi Kudo et al.
JHEP REPORTS (2021)
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2
Masatoshi Kudo et al.
LIVER INTERNATIONAL (2020)
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Pinero et al.
CELLS (2020)
Sequencing Systemic Therapy Pathways for Advanced Hepatocellular Carcinoma: A Cost Effectiveness Analysis
Christopher Sherrow et al.
LIVER CANCER (2020)
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study
Chao-Wei Lee et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
John D. Gordan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma
Ulrik Carling et al.
ACTA RADIOLOGICA (2019)
Shared Decisions and Agency: Better Engagement Tools
Cindy Peterson-Dana
PSYCHIATRIC SERVICES (2019)
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma
Hitomi Takada et al.
CANCERS (2019)
Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
Rong-yun Mai et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma
Zhong-zheng Zhu et al.
CURRENT MEDICAL SCIENCE (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data
Ming-Chin Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up
Hyo Jung Cho et al.
DNA AND CELL BIOLOGY (2016)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma
Ai Shen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Hepatic Resection for Hepatocellular Carcinoma With Lymph Node Metastasis: Clinicopathological Analysis and Survival Outcome
Chao-Wei Lee et al.
ASIAN JOURNAL OF SURGERY (2011)
Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?
Ming-Chin Yu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Jaw-Ching Wu et al.
JOURNAL OF HEPATOLOGY (2009)
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shimul A. Shah et al.
SURGERY (2007)
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
C Cha et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
分享论文
